Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Ejhaem|August 21, 2023
Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapySøren Thorgaard Bønløkke, Marianne Tang Severinsen, Hans Beier Ommen, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 8, 2021
Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery DiseaseOliver Buchhave Pedersen, Anne-Mette Hvas, Hans Beier Ommen, et al.
Pediatric Blood & Cancer|February 15, 2012
Genetic and epigenetic similarities and differences between childhood and adult AMLCaroline Juhl-Christensen, Hans Beier Ommen, Anni Aggerholm, et al.
Case Reports in Hematology|October 26, 2018
Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic EpisodesJonas Juul Hansen, Hans Beier Ommen, Lars Christian Gormsen, et al.
European Journal of Haematology|January 10, 2024
Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia patients transplanted by reduced intensity conditioningJonas Kassow Gronlund, Christopher Veigaard, Caroline Juhl-Christensen, et al.
British Journal of Haematology|June 8, 2022
Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemiaOliver Buchhave Pedersen, Erik Lerkevang Grove, Leonardo Pasalic, et al.
Pediatric Blood & Cancer|March 23, 2019
Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference valuesKristian Løvvik Juul-Dam, Charlotte Guldborg Nyvold, Helen Vålerhaugen, et al.
Blood|November 11, 2009
Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemiasHans Beier Ommen, Susanne Schnittger, Jelena V Jovanovic, et al.
British Journal of Haematology|April 16, 2008
Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervalsHans Beier Ommen, Charlotte Guldborg Nyvold, Karin Braendstrup, et al.
Ugeskrift for Laeger|January 29, 2009
[Minimal residual disease in malignant diseases of the blood II. Translation and therapeutic consequences]Peter Hokland, Hans Beier Ommen, Charlotte Guldborg Nyvold, et al.
Pageof 4